Sherlock, binx to develop point-of-care Covid-19 test using CRISPR technology
The Food and Drug Administration had previously granted an emergency use authorization for Abbott's ID NOW point-of-care test, a decision for which the agency came under fire amid reports of the test delivering inaccurate results.